David Williamson

Montgomery‐Åsberg Depression Rating Scale factors in treatment‐resistant depression at onset of treatment: Derivation, replication, and change over time during treatment with esketamine

Stephane Borentain, Jagadish Gogate, David Williamson et al. · International Journal of Methods in Psychiatric Research · 2022 · 29 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17

Effect of Sleep Disturbance on Efficacy of Esketamine in Treatment-Resistant Depression: Findings from Randomized Controlled Trials

Stephane Borentain, David Williamson, Ibrahim Turkoz et al. · Neuropsychiatric Disease and Treatment · 2021 · 22 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17

Treatment Response With Esketamine Nasal Spray Plus an Oral Antidepressant in Patients With Treatment-Resistant Depression Without Evidence of Early Response

Ibrahim Turkoz, Ella Daly, Jaskaran Singh et al. · The Journal of Clinical Psychiatry · 2021 · 21 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17

Intranasal esketamine effectively treats treatment-resistant depression in adults regardless of baseline irritability

Manish K. Jha, David Williamson, Ghazal Magharehabed et al. · Journal of Affective Disorders · 2022 · 19 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Predictors of response and remission in patients with treatment-resistant depression: A post hoc pooled analysis of two acute trials of esketamine nasal spray

Ibrahim Turkoz, J. Craig Nelson, Samuel T. Wilkinson et al. · Psychiatry Research · 2023 · 18 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17